Semantic Dementia Clinical Trials 2023

What Are Semantic Dementia Clinical Trials?

Semantic dementia is a brain disorder that may be the cause of younger onset dementia. The disorder occurs when nerve cells in the brain are lost, causing the frontal and temporal lobes to get smaller in size. Semantic dementia can affect language, movement, personality, and behavior. People with semantic dementia often have small structures called pick bodies containing tau proteins.

Experts believed that some cases of semantic dementia are inherited, although most people with the disorder don’t have any family history of the condition. More semantic dementia clinical trials are needed to help practitioners with an accurate diagnosis, prevention, and treatment of the disorder.

Why Is Semantic Dementia Being Studied Through Clinical Trials?

Semantic dementia clinical trials focus on understanding how the disorder works, why it develops, and how to treat it effectively. More importantly, there is a focus on how practitioners can improve the lives of patients with the disorder.

It is only through clinical research that the cause of semantic dementia can be properly understood, laying the groundwork for newer treatments and even potential cures that can improve the quality of life for patients.

What Are The Types of Treatments Available For Semantic Dementia?

There is no treatment available to cure or slow the progression of semantic dementia. However, doctors may prescribe medications to manage the symptoms of the disorder. Commonly prescribed medications include antidepressants to treat anxiety and manage any negative behaviors such as obsessive compulsive disorder.

Sleeping aids are also used to ease insomnia and improve the quality of a patient’s sleep. Patients may be asked to undergo speech and physical therapy to adjust to the changes caused by semantic dementia.

What Are Some Recent Breakthrough Clinical Trials For Semantic Dementia?

2005: Neurophysiological Tests and Semantic Dementia - This clinical trial compared patients struggling with various forms of dementia, including semantic dementia. Its goal was to provide clinical instruments for diagnosing the different types of dementia, including semantic dementia and Alzheimer’s disease.

2019: Testing tDCS in Semantic Dementia - The objective of this semantic dementia clinic trial is to study the effectiveness of transcranial direct current stimulation (tDCS) on language impairment. The results of the study were used to seek better treatments for semantic disorders that are both accessible and inexpensive.

Who Are Some Of The Key Opinion Leaders Semantic Dementia Clinical Trial Research?

Clara Sanches is a postdoctoral fellow at the University of California San Francisco. She specializes in cognitive neurosciences and the use of transcranial stimulation as a possible treatment for dementia. Sanches observes how different individuals respond to aging in various aspects of their life to explore various treatment methods that can prevent early cognitive and functional decline.

Richard Levy is an Assistant Professor of Medicine at Boston University. He is a leading researcher in frontotemporal dementia with over 10 years of experience. Levy has taken part in a number of research papers to discover new treatment methods.